Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 82804-176

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 82804-176). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

82804-176-90 (Image 01)

82804-176-90 (Image 01)
Label for Rosuvastatin Calcium 40 mg tablets, a film-coated, pink, oval-shaped, biconvex oral dosage form. The label indicates a quantity of 90 tablets, manufactured by MSN Laboratories Private Limited in India, and packaged by Proficient Rx LP. The label includes identifiers such as Product ID ZR017690 and NDC 82804-176-90, along with barcode and QR codes.*
FDA Label Image

Rosuvastatin-fig-01 (Rosuvastatin Fig 01)

Rosuvastatin-fig-01 (Rosuvastatin Fig 01)
A cumulative incidence line graph comparing Rosuvastatin (solid line) and placebo (dotted line) over a 5-year period. The y-axis represents cumulative incidence percentage, while the x-axis shows time in years. The graph includes annotated hazard ratio (HR 0.56, 95% CI 0.46-0.69) and indicates a statistically significant difference (P<0.001). Number at risk for each group is displayed below the x-axis at various time points.*
FDA Label Image

Rosuvastatin-fig-02 (Rosuvastatin Fig 02)

Rosuvastatin-fig-02 (Rosuvastatin Fig 02)
A data table presenting clinical endpoint comparisons between Rosuvastatin 20 mg and placebo 20 mg groups in a study of 8901 patients each. It lists event numbers, rates, hazard ratios with 95% confidence intervals, and p-values for primary and secondary cardiovascular endpoints, including major cardiovascular events, cardiovascular death, nonfatal stroke, nonfatal myocardial infarction, hospitalized unstable angina, and arterial revascularization. A forest plot graphically depicts hazard ratios with confidence intervals for each endpoint.*
FDA Label Image

Rosuvastatin-fig-03 (Rosuvastatin Fig 03)

Rosuvastatin-fig-03 (Rosuvastatin Fig 03)
A box plot graph comparing percent change from baseline in LDL-C levels across different doses of four statins: Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin. The x-axis shows doses in milligrams for each drug, and the y-axis indicates percent change from 0 to -75.*
FDA Label Image

Structure (Rosuvastatin Structure)

Structure (Rosuvastatin Structure)
Chemical structure of Rosuvastatin Calcium, depicting atoms and bonds including calcium ion (Ca2+) complexation, consistent with the active ingredient in Rosuvastatin Calcium 40 mg tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.